Pagano Livio, Mayor Susan
Institute of Hematology, Fondazione Policlinico Universitario A. Gemelli- Università Cattolica del Sacro Cuore, Rome, Italy.
Medical writer, London, UK.
Future Sci OA. 2018 Jun 14;4(6):FSO307. doi: 10.4155/fsoa-2018-0019. eCollection 2018 Jul.
Trends in Medical Mycology (TIMM) is the biennial meeting of the Infectious Disease Group of the European Organisation for Research and Treatment of Cancer (EORTC) and the European Confederation of Medical Mycology (ECMM). It brings together clinicians and researchers from across the world to share the latest R&Ds in medical mycology. Despite advances in treatment, invasive fungal infections remain a major cause of morbidity and mortality in certain high-risk groups of patients, particularly in immunocompromised patients, including those undergoing solid organ transplantation and those with acute leukemia. The challenges for clinicians are now compounded by the rapid development of multidrug resistance. The latest data and approaches to identifying patients at high risk for invasive fungal infections, ensuring early diagnosis and achieving effective treatment, including when and how to use therapeutic drug monitoring with azoles, were shared with >1000 clinicians and researchers from around the world attending the eighth TIMM, held in Belgrade, Serbia, in October 2017 (TIMM-8 2017).
《医学真菌学趋势》（TIMM）是欧洲癌症研究与治疗组织（EORTC）传染病小组和欧洲医学真菌学联合会（ECMM）的两年一次会议。它汇聚了来自世界各地的临床医生和研究人员，以分享医学真菌学的最新研发成果。尽管在治疗方面取得了进展，但侵袭性真菌感染仍然是某些高危患者群体发病和死亡的主要原因，特别是在免疫功能低下的患者中，包括接受实体器官移植的患者和急性白血病患者。多药耐药性的迅速发展使临床医生面临的挑战更加复杂。2017年10月在塞尔维亚贝尔格莱德举行的第八届TIMM（TIMM - 8 2017）上，与来自世界各地的1000多名临床医生和研究人员分享了关于识别侵袭性真菌感染高危患者、确保早期诊断以及实现有效治疗的最新数据和方法，包括何时以及如何使用唑类药物的治疗药物监测。
